Noninvasive prediction of organ graft rejection and outcome using gene expression patterns

Dany Anglicheau, Manikkam Suthanthiran

Research output: Contribution to journalReview article

66 Citations (Scopus)

Abstract

Development of predictive, diagnostic, and prognostic biomarkers of allograft status and outcome is important and challenging, and may be rewarded with individualized therapy for the organ graft recipient. Herein, we summarize noninvasive messenger RNA profiling studies for ascertaining allograft status and outcome. Nucleic acid-based biomarkers of allograft status have been developed by several laboratories, but the studies have primarily been single center investigations. Ongoing multicenter trials including the Clinical Trials in Organ Transplantation (https://www.ctotstudies.org) should help further to define the clinical utility of noninvasively developed messenger RNA profiles as biomarkers of allograft status and outcome.

Original languageEnglish
Pages (from-to)192-199
Number of pages8
JournalTransplantation
Volume86
Issue number2
DOIs
Publication statusPublished - 27 Jul 2008
Externally publishedYes

Fingerprint

Graft Rejection
Allografts
Transplants
Gene Expression
Biomarkers
Messenger RNA
Organ Transplantation
Nucleic Acids
Multicenter Studies
Clinical Trials
Therapeutics

Keywords

  • Biomarker
  • Diagnosis
  • Immune monitoring
  • mRNA
  • Transplantation

ASJC Scopus subject areas

  • Transplantation

Cite this

Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. / Anglicheau, Dany; Suthanthiran, Manikkam.

In: Transplantation, Vol. 86, No. 2, 27.07.2008, p. 192-199.

Research output: Contribution to journalReview article

@article{f58fec85c12448ed8658b2de9c9090f3,
title = "Noninvasive prediction of organ graft rejection and outcome using gene expression patterns",
abstract = "Development of predictive, diagnostic, and prognostic biomarkers of allograft status and outcome is important and challenging, and may be rewarded with individualized therapy for the organ graft recipient. Herein, we summarize noninvasive messenger RNA profiling studies for ascertaining allograft status and outcome. Nucleic acid-based biomarkers of allograft status have been developed by several laboratories, but the studies have primarily been single center investigations. Ongoing multicenter trials including the Clinical Trials in Organ Transplantation (https://www.ctotstudies.org) should help further to define the clinical utility of noninvasively developed messenger RNA profiles as biomarkers of allograft status and outcome.",
keywords = "Biomarker, Diagnosis, Immune monitoring, mRNA, Transplantation",
author = "Dany Anglicheau and Manikkam Suthanthiran",
year = "2008",
month = "7",
day = "27",
doi = "10.1097/TP.0b013e31817eef7b",
language = "English",
volume = "86",
pages = "192--199",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Noninvasive prediction of organ graft rejection and outcome using gene expression patterns

AU - Anglicheau, Dany

AU - Suthanthiran, Manikkam

PY - 2008/7/27

Y1 - 2008/7/27

N2 - Development of predictive, diagnostic, and prognostic biomarkers of allograft status and outcome is important and challenging, and may be rewarded with individualized therapy for the organ graft recipient. Herein, we summarize noninvasive messenger RNA profiling studies for ascertaining allograft status and outcome. Nucleic acid-based biomarkers of allograft status have been developed by several laboratories, but the studies have primarily been single center investigations. Ongoing multicenter trials including the Clinical Trials in Organ Transplantation (https://www.ctotstudies.org) should help further to define the clinical utility of noninvasively developed messenger RNA profiles as biomarkers of allograft status and outcome.

AB - Development of predictive, diagnostic, and prognostic biomarkers of allograft status and outcome is important and challenging, and may be rewarded with individualized therapy for the organ graft recipient. Herein, we summarize noninvasive messenger RNA profiling studies for ascertaining allograft status and outcome. Nucleic acid-based biomarkers of allograft status have been developed by several laboratories, but the studies have primarily been single center investigations. Ongoing multicenter trials including the Clinical Trials in Organ Transplantation (https://www.ctotstudies.org) should help further to define the clinical utility of noninvasively developed messenger RNA profiles as biomarkers of allograft status and outcome.

KW - Biomarker

KW - Diagnosis

KW - Immune monitoring

KW - mRNA

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=49249087744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49249087744&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e31817eef7b

DO - 10.1097/TP.0b013e31817eef7b

M3 - Review article

C2 - 18645476

AN - SCOPUS:49249087744

VL - 86

SP - 192

EP - 199

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 2

ER -